SCHEMBL24252619

SCHEMBL24252619

Nc1cnnc2cc(-c3cc(B(O)O)ccc3N3CCOCC3)ccc12

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE10A Q9Y233 1/20 0.40
LRRK2 Q5S007 3/20 0.39
NCF1 P14598 1/20 0.34
ALDH1A1 P00352 2/20 0.34
GAA P10253 2/20 0.34
MAPT P10636 2/20 0.34
MEN1 O00255 1/20 0.34
POLB P06746 1/20 0.34
THRB P10828 1/20 0.34
RECQL P46063 1/20 0.34
BLM P54132 1/20 0.34
KMT2A Q03164 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
PIK3CA P42336 3/20 0.34
PIK3CD O00329 2/20 0.34
PIK3CB P42338 2/20 0.34
PIK3CG P48736 2/20 0.34
CCNA2 P20248 1/20 0.34
CDK2 P24941 1/20 0.34
CCNA1 P78396 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Formic Acid SCHEMBL25240502 0.95 LRRK2 (0.39) PDE10ALRRK2NCF1ALDH1A1GAA
Formic Acid SCHEMBL30467686 0.95 LRRK2 (0.39) PDE10ALRRK2NCF1ALDH1A1GAA
SCHEMBL26771355 0.92 PDE10A (0.41) PDE10ALRRK2NCF1ALDH1A1GAA
SCHEMBL24252672 0.92 FEN1 (0.36) PDE10ANCF1ALDH1A1GAAPOLB
SCHEMBL25240499 0.87 PDE10A (0.37) PDE10ALRRK2NCF1PIK3CAPIK3CD
Formic Acid SCHEMBL30467631 0.87 FEN1 (0.33) GAAPOLBL3MBTL1PIK3CAPIK3CD
Formic Acid SCHEMBL25250167 0.87 FEN1 (0.33) GAAPOLBL3MBTL1PIK3CAPIK3CD
SCHEMBL26771374 0.83 FEN1 (0.35) PDE10ANCF1ALDH1A1GAAMAPT
SCHEMBL25840702 0.82 PLG (0.34) PDE10A
SCHEMBL30462795 0.79 PLG (0.31)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11814404-B2 Inhibitors of complement factors and uses thereof ANNEXON, INC. (US) 2023-11-14 US disclosed
US-11814404-B2 Inhibitors of complement factors and uses thereof ANNEXON, INC. (US) 2023-11-14 US disclosed
US-20220048930-A1 INHIBITORS OF COMPLEMENT FACTORS AND USES THEREOF ANNEXON, INC. 2022-02-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220048930-A1 INHIBITORS OF COMPLEMENT FACTORS AND USES THEREOF CFB, CFH, C9 PDE10A 1950/4885LRRK2 1477/4885NCF1 166/4885
US-11814404-B2 Inhibitors of complement factors and uses thereof CFB, CFH, C9 PDE10A 1950/4885LRRK2 1477/4885NCF1 166/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.